Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Karo Pharma AB buy Morgan Stanley

Start price
€5.44
22.04.24 / 50%
Target price
€29.08
22.04.25
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 22.04.25. The prediction end date can be changed by Morgan_Stanley at any time.
Performance without dividends (%)
Name 1w
Karo Pharma AB -
iShares Core DAX® -0.922%
iShares Nasdaq 100 0.371%
iShares Nikkei 225® 2.224%
iShares S&P 500 -0.026%

Comments by Morgan_Stanley for this prediction

In the thread Karo Pharma AB diskutieren
Prediction Buy
Perf. (%) -
Target price 29.078
Change
Ends at 22.04.25

Karooooo Ltd. (NASDAQ: KARO) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $31.00 price target on the stock.
Ratings data for KARO provided by MarketBeat

Stopped prediction by Morgan_Stanley for Karo Pharma AB

buy
Karo Pharma AB

Start price
Target price
Perf. (%)
€5.44
24.01.24
€28.46
24.01.25
-
24.11.22

buy
Karo Pharma AB

Start price
Target price
Perf. (%)
€5.44
31.07.23
€30.83
31.07.24
-
24.11.22

buy
Karo Pharma AB

Start price
Target price
Perf. (%)
€5.44
24.07.23
€30.66
24.07.24
-
24.11.22